Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm

Clin Genitourin Cancer. 2017 Oct;15(5):e897-e901. doi: 10.1016/j.clgc.2017.05.018. Epub 2017 May 25.
No abstract available

Keywords: PD1/PDL-1 inhibitor; Renal cell cancer; Sarcomatoid differentiation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / radiotherapy
  • Female
  • Humans
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / radiotherapy
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Nivolumab
  • Palliative Care
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Nivolumab